JPRN-UMIN000013022
尚未招募
4 期
Multicentre, randomized, double blind, placebo-controlled study to evaluate the effect of pancreatic enzyme replacement therapy on glucose metabolism, nutritional parameters, incretin response and beta-cell function in patients with diabetes mellitus and exocrine pancreatic insufficiency - Pancreatic enzyme replacement therapy in diabetes mellitus and exocrine pancreatic insufficiency
First Department of Internal Medicine, Szeged0 个研究点目标入组 120 人2014年2月1日
概览
- 阶段
- 4 期
- 干预措施
- 未指定
- 疾病 / 适应症
- The licensing phase
- 发起方
- First Department of Internal Medicine, Szeged
- 入组人数
- 120
- 状态
- 尚未招募
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- 未提供
排除标准
- •\-Patients with any severe diseases \-Any type of malignancy \-Any history of gastrointestinal surgery, \-Any known reason for maldigestion or malabsorption \-Any history of alcohol or drug abuse \-Proven gastroparesis or diarrhea \-Females with existing or intended pregnancy or breast\-feeding, or not using adequate birth control
结局指标
主要结局
未指定
相似试验
进行中（未招募）
1 期
Multicentre, double-blind, randomized, placebo-controlled, parallel-group, clinical trial to evaluates the clinical efficacy and safety of immunotherapy with purified major allergen Alt a 1 in patients with allergic rhinoconjunctivitis with or without mild to moderate asthma, sensitized the fungus Alternaria alternataEUCTR2010-024440-15-ESDIATER Laboratorio de Diagnostico y Aplicaciones Terapéuticas S.A.
进行中（未招募）
1 期
Study on the treatment of the mild congnitive impairment due to Alzheimer's disease with Zinc SulphateEUCTR2019-000604-15-ITIVERSITÀ DEGLI STUDI G. D'ANNUNZIO CHIETI-PESCARA215
进行中（未招募）
1 期
Multicentre, randomized, double-blind, placebo-controlled, non-commercial clinical trial to evaluate the efficacy and safety of specific anti-SARS-CoV-2 immunoglobulin in the treatment of COVID-19CoronaVirus Disease 2019Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2020-005410-18-PLSamodzielny Publiczny Szpital Kliniczny Nr 1 w Lublinie Samodzielny Publiczny Zaklad Opieki Zdrowotnej480
招募中
1 期
Study to evaluate the efficacy and safety of low-dose aspirin as an add-on to standard therapy in patients with bipolar disorder (ASPIRIN BD)Bipolar Affective DisorderMedDRA version: 21.1Level: LLTClassification code: 10004908Term: Bipolar affective disorder Class: 10037175Therapeutic area: Diseases [C] - Nervous System Diseases [C10]CTIS2024-516584-86-00Instytut Psychiatrii I Neurologii100
进行中（未招募）
不适用
Multicentre, randomized, double-blind, placebo-controlled clinical trial to evaluate the short-term efficacy and safety of two different treatment regimens of Betamethasone valerate 2.25 mg medicated plaster in patients with chronic tendinopathies of the upper and lower limbsEUCTR2012-005030-11-ITIBSA INSTITUT BIOCHIMIQUE SA